Retrospective analysis of diffuse large B-cell lymphoma treated with the R-CHOP regimen at a Malaysian tertiary hospital
Alvin Jung Mau Chai, Tze Shin Leong, Grace Wan Chieng Lee, Lee Ping Chew · 2025
Read Retrospective analysis of diffuse large B-cell lymphoma treated with the R-CHOP regimen at a Malaysian tertiary hospital by Alvin Jung Mau Chai, Tze Shin Leong, Grace Wan Chieng Lee, Lee Ping Chew (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12781267.txt.
Description
Alvin Chai and co-authors review lymphoma care outcomes at a Malaysian tertiary hospital. Diffuse large B-cell lymphoma is the most common lymphoma in Malaysia and worldwide. Records covered 202 patients treated from 2015 to 2020 with the R-CHOP drug mix. Median age was fifty-eight, and most patients were men.
Complete response came for about fifty-eight percent of patients. Three-year survival sat near sixty-one percent, with progression-free survival close behind. High prognostic index scores and B symptoms both marked worse paths. Low blood albumin stood alone as an independent death risk in deep analysis. The authors call for bigger prospective trials with longer follow-up.
Catalog record
| CREATOR | Alvin Jung Mau Chai, Tze Shin Leong, Grace Wan Chieng Lee, Lee Ping Chew |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |